Endogenous opiates and behavior: 2005

RJ Bodnar, GE Klein - Peptides, 2006 - Elsevier
This paper is the 28th consecutive installment of the annual review of research concerning
the endogenous opioid system, now spanning over a quarter-century of research. It …

Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates

N Albelda, D Joel - Neuroscience & Biobehavioral Reviews, 2012 - Elsevier
During the last 30 years there have been many attempts to develop animal models of
obsessive-compulsive disorder (OCD). Most models have not been studied further following …

Animal models of obsessive–compulsive disorder: utility and limitations

P Alonso, C López-Solà, E Real… - Neuropsychiatric …, 2015 - Taylor & Francis
Obsessive–compulsive disorder (OCD) is a disabling and common neuropsychiatric
condition of poorly known etiology. Many attempts have been made in the last few years to …

[HTML][HTML] The role of dynorphin and the kappa opioid receptor in the symptomatology of schizophrenia: a review of the evidence

SD Clark, A Abi-Dargham - Biological psychiatry, 2019 - Elsevier
Schizophrenia is a debilitating mental illness that affects approximately 1% of the world's
population. Despite much research in its neurobiology to aid in developing new treatments …

Multigenerational effects of adolescent morphine exposure on dopamine D2 receptor function

JJ Byrnes, NL Johnson, LM Carini, EM Byrnes - Psychopharmacology, 2013 - Springer
Rationale The use and misuse of prescription opiates in adolescent populations, and in
particular, adolescent female populations, has increased dramatically in the past two …

κ-Opioid receptor activation in dopamine neurons disrupts behavioral inhibition

AD Abraham, HM Fontaine, AJ Song… - …, 2018 - nature.com
The dynorphin/κ-opioid receptor (KOR) system has been previously implicated in the
regulation of cognition, but the neural circuitry and molecular mechanisms underlying KOR …

Crosstalk between kappa opioid and dopamine systems in compulsive behaviors

AP Escobar, JP Casanova, ME Andrés… - Frontiers in …, 2020 - frontiersin.org
The strength of goal-oriented behaviors is regulated by midbrain dopamine neurons.
Dysfunctions of dopaminergic circuits are observed in drug addiction and obsessive …

Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study

S Pallanti, S Bernardi, S Antonini, N Singh, E Hollander - CNS drugs, 2009 - Springer
Background: Serotonin and dopamine neuronal systems have been implicated in the
modulation of obsessive-compulsive disorder (OCD) symptoms. About 40% of OCD patients …

Challenges in the diagnosis and treatment of pediatric obsessive–compulsive disorder

C Westwell-Roper, SE Stewart - Indian journal of psychiatry, 2019 - journals.lww.com
Obsessive–compulsive disorder (OCD) affects 1%–3% of children worldwide and has a
profound impact on quality of life for patients and families. Although our understanding of the …

Are 5‐HT3 antagonists effective in obsessive–compulsive disorder? A systematic review of literature

D Serata, GD Kotzalidis, C Rapinesi… - Human …, 2015 - Wiley Online Library
Objective The purpose of this literature database search‐based review was to critically
consider and evaluate the findings of literature focusing on efficacy and safety of 5‐HT3 …